Initial public offerings (IPOs) have skyrocketed so far in 2014, particularly for new biotech firms. According to the Financial Times, eight biotech firms raised a total of more than $500 million last week alone.
Here�� a look at two IPOs from last week that were not biotech firms and two of the biotechs��IPOs.
Ladder Capital Corp. (NYSE: LADR) priced its offering of 13.25 million shares on Wednesday night at $17, at the mid-point of its expected range of $16 to $18 a share. Underwriters have a 30-day option on an additional 1.99 million shares. Ladder raised approximately $226 million in the IPO. Shares opened Thursday at around $16.50 but finished the first day of trading at $16.99. They closed Friday at $17.30. Ladder is a commercial real-estate finance firm that uses a proprietary platform to originate conduit loans. It bundles the loans and sells them commercial backed mortgage securities (CMBS).
Continental Building Products Inc. (NYSE: CBPX) priced its IPO on Tuesday night at $14, below the expected range of $16 to $18 a share. Shares opened at $14.52 on Wednesday and hit an intraday high of $17.74 on Thursday. They closed on Friday at $17.30. The company raised $165.2 million on the offering of 11.8 million shares. The company makes and sells gypsum board to the construction industry.
5 Best New Stocks To Watch Right Now: Citadel Capital SAE (CCAP)
Citadel Capital SAE is an Egypt-based company engaged in the private equity investment activities. The Company manages an investment portfolio that consist of 19 Opportunity-Specific Funds (OSFs), which controls entities platform distributed across 12 countries in the Middle Eastern and North African markets, and span 14 industrial sector such as energy, cement manufacturing, solid waste management, real estate, mining, agricultural, glass manufacturing, transportation and metallurgy. Its OSFs entities include Asec Holding, Ascom Geology and Mining SAE, Nile Logistics, Rift Valley Railways, Gozour, Wafra, Nopc / Rally Energy Group, Nile Valley Petroleum Ltd, Egyptian Refining Company, Taqua Arabia, GlassWorks and Finance Unlimited, among others. On December 9, 2012, the Company announced that it has sold 100% of its interest in National Petroleum Company Egypt Limited (NPC Egypt), a wholly owned portfolio company, to Sea Dragon Energy Inc. Advisors' Opinion:- [By Joshi Madhavi]
Charlemagne Capital Limited (CCAP) is an established asset management group in the UK with an exclusively emerging markets focus and bottom-up stock picking process. The business is cyclical with fortunes linked to emerging market performance. The company�� strategy is to grow each category within its broad fund range: mutual funds, hedge funds, specialist funds and institutional products.
Top 10 Building Product Stocks For 2014: Vonage Holdings Corp.(VG)
Vonage Holdings Corp. provides broadband communication services in the United States, Canada, and the United Kingdom. The company offers voice and messaging services through session initiation protocol (SIP) based voice over Internet protocol network. The company?s primary product offering is Vonage World, a residential plan with unlimited calling domestically and to approximately 60 countries, including India, Mexico, and China for a flat monthly rate. It also provides broadband telephone replacement services to residential, small office, and home office customers through various service plans with a range of basic features, including call waiting, caller ID with name, call forwarding, and voicemail. In addition, the company offers mobile services through mobile applications that can be downloaded for iPhone, iPad, iPod touch, and Android OS devices. Further, the company provides Vonage Mobile, a free downloadable mobile application that provides free calling and messagi ng between users who have the application, as well as traditional paid international calling to any other phone. It markets its services through in-bound telemarketing and online direct sales, as well as through regional and national retailers. As of December 31, 2011, the company had approximately 2.4 million subscriber lines. Vonage Holdings Corp. was incorporated in 2000 and is headquartered in Holmdel, New Jersey.
Advisors' Opinion:- [By Luke Jacobi]
Vonage Holdings (NYSE: VG) was up early on in Thursday's session, gaining 16.07 percent to $3.54 after news broke that the company would acquire Vocalocity for $130 million.
Top 10 Building Product Stocks For 2014: NetApp Inc.(NTAP)
NetApp, Inc. engages in the design, manufacturing, marketing, and technical support of networked storage solutions. It supplies enterprise storage and data management software, and hardware products and services. The company offers Data ONTAP, an operating system that supports storage area network (SAN) and network-attached storage (NAS) environments; storage efficiency technologies, including FlexVol, FlexClone, and Deduplication technologies; storage management and application integration software, such as OnCommand management software; fabric-attached storage unified storage systems, which support a range of data for users on various platforms; and virtual storage tier; V-Series network-based virtualization solutions that provide SAN and NAS access to the data stored in heterogeneous storage arrays. It also provides data protection software products, including Snapshot, SnapRestore, SnapVault, and Open Systems SnapVault techologies; MetroCluster products; and SnapMirror data replication solution. In addition, the company offers data retention and archive products, and Flash Cache modules; and storage security products for data security and key management in IP SAN, NAS, and tape backup environments; StorageGRID that enables intelligent data management and secure content retention; and professional services, global support solutions, and customer education and training. It serves energy, financial services, government, high technology, Internet, life sciences and healthcare services, manufacturing, media, entertainment, animation and video postproduction, and telecommunications industries. It offers its products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and Japan. The company was formerly known as Network Appliance, Inc. and changed its name to NetApp, Inc. in March 2008. NetApp, Inc. was founded in 1992 and is headquartered in Sunnyvale, California.
Advisors' Opinion:- [By Jonas Elmerraji]
2013 has been a strong year for shares of NetApp (NTAP) too -- just not quite as strong as Activision's. NTAP has seen its shares rally close to 24% year-to-date, outpacing the S&P's climb by nearly 10% this year. And again, NetApp's huge net cash position washes a lot of the risk out of shares.
NetApp sells data management hardware, software and services to enterprise IT customers across the world. The firm's biggest business comes from selling network attached storage, devices that can connect to clients' existing networks to boost capacity without other huge changes to their existing tech infrastructure. That makes it an ideal vendor for firms whose storage needs are gradually increasing (and those who don't want to shell out massive capital for all-new IT infrastructure). As cloud computing continues to ramp up demand for computer storage, NTAP is finding itself on the right side of a very lucrative trend.
That trend has transformed into cash. Right now, NetApp has $4.09 billion in cold, hard cash on its balance sheet -- a safety net that covers 27% of this stock's current market capitalization. As long as management can figure out a smart way to earn returns on that big cash balance (or return it to shareholders), expect NTAP to perform well.
- [By MONEYMORNING.COM]
According to IDC estimates, EMC's share of the storage hardware segment is more than 30%. That's about two-and-a-half times that of its nearest competitor, NetApp Inc. (Nasdaq: NTAP).
Top 10 Building Product Stocks For 2014: Gladstone Commercial Corporation(GOOD)
Gladstone Commercial Corporation operates as a real estate investment trust (REIT) in the United States. It engages in investing in and owning net leased industrial and commercial real properties, and making long-term industrial and commercial mortgage loans. The company leases its real estate properties to small businesses, as well as to large public companies. As of December 31, 2009, it owned 64 properties, and held 1 mortgage loan. The company qualifies as a REIT under the Internal Revenue Code of 1986. As a REIT, it would not be subject to federal tax to the extent that it distributes at least 90% of its taxable income to its shareholders. The company was founded in 2003 and is based in McLean, Virginia.
Advisors' Opinion:- [By GURUFOCUS]
Gladstone Commercial Corporation (GOOD) operates as a real estate investment trust (REIT) in the United States.Yield: 7.9%
Main Street Capital Corporation (MAIN) is a business development company specializing in long- term equity, equity related, and debt investments in small and lower middle market companies. Yield: 6.3%
Top 10 Building Product Stocks For 2014: SL Green Realty Corporation(SLG)
SL Green Realty Corp. is a real estate investment trust (REIT). The firm engages in the property management, acquisitions, financing, development, construction, and leasing. It also provides tenant services to its clients. The firm invests in real estate markets of the United States. It primarily invests in commercial office and retail properties. SL Green Realty Corp. was founded in 1970 and is based in New York, New York.
Advisors' Opinion:- [By Marc Bastow]
Property management and financing real estate investment trust SL Green Realty (SLG) raised its quarterly dividend 52% to 50 cents per share. SLG did not release a payment or ex-dividend date for the new dividend.
SLG Dividend Yield:�2.04%
Top 10 Building Product Stocks For 2014: Rentech Nitrogen Partners LP (RNF)
Rentech Nitrogen Partners, L.P. is a provider of clean energy solutions and nitrogen fertilizer, to own, operate and grow its nitrogen fertilizer business. The Company primarily produces anhydrous ammonia, or ammonia, and urea ammonium nitrate solution (UAN), at the Company�� facility, using natural gas as its primary feedstock. In November 2012, the Company acquired Agrifos LLC.
The Company�� facility is located in the center of the Mid Corn Belt. The Mid Corn Belt includes the States of Illinois, Indiana, Iowa, Missouri, Nebraska and Ohio. The Company considers its market to be consisted of the States of Illinois, Iowa and Wisconsin.
Advisors' Opinion:- [By Sally Jones] urrent share price is $17.34, or 64.7% off the 52-week high of $49.18.
Down 54% over 12 months, RNF has a market cap of $673.66 million, and trades with a P/B of 13.30. The dividend yield is 13.67%.
Rentech Nitrogen Partners LP is a pure-play nitrogen fertilizer company structured as a publicly traded master limited partnership. The company manufactures and sells nitrogen fertilizer products including ammonia, UAN solution and ammonium sulfate.
Guru Action: As of Sept. 30, 2013, there is one guru stakeholder and one recent insider sell.
As of Sept. 30, 2013, the sole guru owner Jim Simons reduced his position by 14.04%, selling 49,490 shares at an average price of $28.06 for a loss of 38.2%.
Over four losing quarters, he has averaged a loss of 52% on 352,600 shares at an average price of $36.30 per share. Selling, he has averaged a loss of 38% on 49,490 shares at an average price of $28.06 per share.
His current shares of 303,110 represent 0.78% of shares outstanding.
Track share pricing, revenue and net income:
Highlight: Turquoise Hill Resources Ltd. (TRQ)
The current share price is $3.25, or 66.2% off the 52-week high of $9.62.
Down 57% over 12 months, TRQ has a market cap of $3.27 billion, and trades with a P/B of 0.60. The company does not pay a dividend.
Turquoise Hill Resources Ltd. is an international mining company focused on copper, gold and coal mines in the Asia Pacific region. The company has other projects containing molybdenum, rhenium, copper, gold, zinc, silver and uranium.
Guru Action: As of Sept. 30, 2013, there are six guru stakeholders and one recent insider trade.
The top guru owner is RS Investment Management who increased its position by 29.59% in the third quarter of 2013, buying 13,234,642 shares at an average price of $5.12 for a loss of 36.5%.
Over six losing quarters, the firm has averaged a loss of 55% on 57,968,897 shares at an average price
Top 10 Building Product Stocks For 2014: Gilead Sciences Inc.(GILD)
Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Emtriva for the treatment of human immunodeficiency virus infection in adults; Hepsera, an oral formulation for the treatment of chronic hepatitis B; AmBisome, a amphotericin B liposome injection to treat invasive fungal infections; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa for the treatment of chronic angina; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Cayston, an inhaled antibiotic used as a treatment to enhance respiratory systems. The company?s products also comprise Tamiflu, an oral antiviral for the treatment and prevention of influenza A and B; Macugen, an intravitreal injection for the treatment of neovascular a ge-related macular degeneration; and Lexiscan/Rapiscan, an injection used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. Its products under the Phase III clinical trials consist of Cobicistat, a pharmacoenhancer that is under evaluation as a boosting agent for HIV medicines; Elvitegravir, an oral integrase inhibitor being evaluated as part of combination therapy for HIV; Integrase Single-Tablet, a ?Quad? regimen of elvitegravir, cobicistat, tenofovir disoproxil fumarate, and emtricitabine for the treatment of HIV/AIDS in treatment-naive patients; and Aztreonam for inhalation solution for the treatment of cystic fibrosis patients with Pseudomonas aeruginosa. The company?s Phase II clinical trials products comprise Cicletanine, Ranolazine, and Aztreonam, as well as GS 9190, GS 9256, and GS 9451. Its Phase I clinical trial products include GS 7340, GS 5885, GS 6620, GS 9620, and GS 6624. The company was founded in 1987 and is headquartered in Fost er City, California.
Advisors' Opinion:- [By Ben Levisohn]
Citigroup’s Yaron Werber and team upped their price target on Gilead Sciences (GILD) to $139 from $111. They explain why:
Associated PressFrom our discussions with mgt, Gilead looks very optimistic about
FY15 and anticipates that hepC treatment volumes could be up substantially over FY14 rates globally. This will be driven by the availability of [Sofosbuvir/Ledipasvir, or] SOF/LDV that is easier to take, will be prescribed by more physicians with potentially 3x-4x more capacity, will reverse the ongoing warehousing that reached 50%-66% of patients in some clinics, and will be further supported by a global rollout (EU, Egypt, Japan). While investors are anxious that the hepC market will flatten out in FY15, we are much more optimistic and are raising ests substantially.From the health insurance perspective, the average unit cost of treating Hepatitis C is likely to fall 35% after Oct 10th ��However, even with the lower unit cost, overall Hepatitis C costs are likely to rise meaningfully, as utilization should increase substantially, creating a source of earnings pressure for the insurers, particularly in Q4. Sovaldi shouldn�� be as much of an EPS issue in 2015, as plans have presumably done a better job factoring the incremental costs into pricing…
We expect the recent stock/warrants buybacks to boost Q4 EPS substantially and future stock buybacks will drive appreciation…
Shares of Gilead Sciences are little changed at $105.90 at 12:48 p.m. That leaves 31% of upside to Werber’s target price of $139. The iShares Nasdaq Biotechnology ETF (IBB) has dropped 0.6% to $273.60 today.
- [By Ben Levisohn]
Acorda has dropped 6.3% to $33.12 today at 2pm, while MannKind has gained 5.1% to $5.37. Vertexs Pharmaceuticals (VRTX) has gained 3.3% to $73.25, Celldex Therapeutics (CLDX) has jumped 2.4% to $27.86 and Gilead Sciences (GILD) has ticked up 0.8% to $63.18.
No comments:
Post a Comment